Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Actilyse 50mg Powder and Solvent for Solution for Injection and Infusion - PA0775/011/003
- Alprazolam 0.25mg Tablets - PA0711/140/001
- Brevibloc Premixed 10mg/ml Solution for Infusion - PA2299/021/002
- Buscopan Ampoules 20mg/ml Solution for Injection - PA23180/016/001
- Canesten Combi Pessary & Cream - PA1410/039/001
- Canesten Thrush Cream - PA1410/039/012
- Epilim Chronosphere 500mg Prolonged-Release Granules - PA0540/150/007
- Gerax 500mcg Tablets - PA1445/024/002
- Minims Oxybuprocaine Hydrochloride 0.4% w/v Eye Drops- PA23259/015/001
- Minims Povidone Iodine 5% w/v Eye Drops - PA22698/015/001
- Minims Proxymetacaine hydrochloride 0.5% w/v, Eye Drops - PA22698/017/001
- Minims Tetracaine Hydrochloride 1% w/v Eye Drops - PA23259/022/002
- Minims Tropicamide 0.5% w/v Eye Drops - PA23259/023/001
- Minims Tropicamide 1%w/v Eye Drops - PA23259/023/002
- Pantoflux 40mg Gastro Resistant Tablets - PA2315/187/002
- Raporsin 8mg Prolonged Release Tablets - PA2315/005/001
- Roactemra 162mg Solution for Injection - EU/1/08/492/009
- Solpadeine Soluble Tablets (12 pack and 60 pack) - PA1186/011/001
- Subutex 2mg Sublingual Tablets - PA22617/001/002
The following shortages have been resolved and supply has resumed to the Irish market:
- Cetrotide 0.25mg Powder and Solvent for Solution for Injection - EU/1/99/100/001
- Gamanil 70mg Film Coated Tablets - PA1701/004/001
- Lyrica 25mg Hard Capsules (84 pack) - EU/1/04/279/004
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.